Builders Fund

Builders Fund

Builders Fund launched in 2015 when co-founders Tripp Baird and Katherine O'Hara structure a growth-equity vehicle designed to bridge institutional asset management with the long-duration mindset typical of single-family offices. Baird's background includes directing investments for a prominent West Coast family office, where he developed the conviction that meaningful environmental and social impact could compound into durable competitive moats. The firm organizes around a central premise: the most significant economic transitions of the next two decades — decarbonization, supply-chain reinvention, and chronic-disease reversal — will reward capital patient enough to underwrite multi-year business-model transformations rather than quarterly milestones. The strategy concentrates on lower-middle-market growth equity, typically deploying $10 million to $25 million per position in commercial-stage companies across three macro themes: sustainable food and agriculture, preventive health and well-being, and resource-efficient industrial systems. Rather than spraying small checks across dozens of names, Builders Fund deliberately maintains a portfolio concentrated enough that its partners can serve as active board resources. Confirmed investments include Loliware, a materials-science business replacing single-use plastics with seaweed-derived alternatives, and Urban Remedy, an organic food-as-medicine platform that distributes through Whole Foods and direct-to-consumer channels (per Crunchbase and public record). Geographic emphasis tilts toward North American companies with scalable distribution into European and Asian markets. The team operates from Palo Alto, positioning itself within both Silicon Valley's innovation pipeline and the concentrated network of West Coast family offices that often co-invest alongside Builders. While exact AUM and headcount remain undisclosed, the firm's partnership model suggests a lean senior team backed by operating advisors with domain depth in regenerative agriculture, clinical nutrition, and industrial efficiency. The vehicle structure blends direct equity with occasional special-purpose vehicles for larger follow-on rounds — a hybrid that provides institutional LPs access typically reserved for direct family-office balance sheets. What distinguishes Builders structurally is its unusual synthesis of two archetypes that rarely coexist in a single platform: the orthodox ESG growth-equity manager and the family-office co-investment circle. Most impact-oriented funds market themselves to institutions constrained by liquidity and IRR targets; most family offices hoard the patience advantage for themselves. Builders Fund attempts to institutionalize the latter's time horizon without becoming the former, offering a growth-equity product engineered around the conviction that 10-year regenerative-agriculture transitions or clinical-behavior-change platforms cannot be underwritten on five-year venture clocks — and that the families who understand this want a shared vehicle, not a bespoke separate account.